Our work aids in dissociating the neural substrates that mediate the anorectic effects from those that contribute to the feeling of illness following either endogenous GLP-1R signaling or delivery of GLP-1R agonists for obesity and diabetes treatment. This evidence concerns the gene GLP1R and diabetes mellitus.